FDA plans ultra-fast review of three psychedelic drugs following Trump directive
- Posted on April 24, 2026
- By The Toronto Star
- 0 Views
- 1 min read
FDA plans ultra-fast review of three psychedelic drugs following Trump directive

WASHINGTON (AP) — The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest